Navigation Links
Cost-effectiveness of cetuximab in metastatic colorectal cancer
Date:8/7/2009

From a health-care system perspective, it may be more efficient to use the drug cetuximab only in colorectal cancer patients whose tumors have a wild-type KRAS gene, according to a study published online August 7 in the Journal of the National Cancer Institute.

Earlier, patients whose tumors harbored wild-type KRAS were found to have a higher survival advantage when treated with cetuximab in a randomized trial by the National Cancer Institute of Canada Clinical Trials Group.

In this study, Nicole Mittmann, of the HOPE Research Centre Sunnybrook Health Sciences Centre, in Toronto, and colleagues used prospectively collected resource utilization and health utility data from that trial to conduct a cost-effectiveness analysis to determine the costs per life-year gained and costs per quality-adjusted life-year gained.

Mean survival times for the study arms were calculated over an 18- to 19-month period for all patients in the study and for patients whose tumors had wild-type KRAS.

For all patients, cetuximab showed very high (i.e., unfavorable) incremental cost-effectiveness ratiosmeaning it was very costly in relation to benefitscompared with best supportive care. The incremental cost-effectiveness ratios were, however, more favorable for patients whose tumors harbored wild-type KRAS.

"Consequentlyit would not be efficient to fund cetuximab treatment for all patients with advanced colorectal cancer," the authors write. "Use of cetuximab may be restricted based on a patient's tumor KRAS status."

In an accompanying editorial, Robin Yabroff, Ph.D., of the Division of Cancer Control and Population Science, National Cancer Institute in Bethesda, Md., and Deborah Schrag, M.D., of the Dana Farber Cancer Institute in Boston, note that these findings help raise important questions about how cost-effectiveness analyses inform coverage decisions.

Ideally, personalization of cancer therapy could save
'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
2. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
3. Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy
4. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
5. Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells
6. Researchers identify new method to selectively kill metastatic melanoma cells
7. Chicago team uses artificial intelligence to diagnose metastatic cancer
8. Smoking increases potential for metastatic pancreatic cancer
9. Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
10. Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers and Improves Patient Survival
11. 2-drug combination appears safe and active in metastatic kidney cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... March 26, 2015 Behavioral Research ... firm, announced the release of BathroomMap® , a ... increase access to public restrooms for travelers, especially those ... apps, BathroomMap does not facilitate a paid, social or ... identify and rate local establishments that have clean, available ...
(Date:3/26/2015)... March 26, 2015 Saving Moses is ... it is most needed but least available. As one ... to six clinics in the Benguela province of Angola ... During a recent visit to their clinics, staff employed ... mothers and their babies in a nation the The ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... 30th “Introduction to Hyperbaric Medicine” course, which is ... Society (UHMS) and the National Board of Diving ... the 40-hour course 4 times a year at ... the NY tri-state region; registration is available on-line ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... Getting details in writing would be ideal, survey finds , ... how long it takes to receive the results of radiology ... they do get the results, a U.S. study has found. ... X-ray. , "Most of the patients in our study were ...
... A patient,s socioeconomic status (income, martial status and race) ... radiation therapy for the treatment of prostate cancer, according ... Detroit. "This study offers an extremely ... receive radiation therapy," says Benjamin Movsas, M.D., senior study ...
... of Allergy and Infectious Diseases (NIAID), part of the ... to two programs that support research to better understand ... diseases, including those that may be introduced into a ... awarded to the Cooperative Centers for Translational Research on ...
... the H1N1 pandemic and West Nile virus -- as ... and environmental changes -- has prompted experts to look ... human, and environmental health. In turn, the nonprofit ... for improved collaboration across human, animal, and ecosystem health ...
... drowsy motorists, survey suggests , WEDNESDAY, Nov. 4 (HealthDay News) ... -- have had accidents or near-misses over the past year ... , Also, more than half of drivers surveyed admitted ... and 28 percent said they drive while sleepy at least ...
... , ... Future-focused performance management system prepares hospital leaders for the changing health care environment. ... ... extreme financial challenges—payment reform, reimbursement changes and a shift of patient services to ...
Cached Medicine News:Health News:Waiting, Wondering About Radiology Results Irks Patients 2Health News:Does race, income predict prostate cancer outcome? 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 3Health News:Sleepy Drivers a Menace on the Road 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 3
(Date:3/26/2015)... , March 26, 2015 ... please scroll to bottom . Investor-Edge has ... MYL ), Salix Pharmaceuticals Ltd (NASDAQ: SLXP ... (NASDAQ: VVUS ), and Akorn Inc. (NASDAQ: ... accessed at http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined ...
(Date:3/26/2015)... , Kalifornien, 26. März 2015 /PRNewswire/ ... Cellworld 2015, die sich speziell an Innovatoren, ... an. Die zweitägige Konferenz für ... September 2015 im Hyatt Regency in ... In diesem Forum werden führende Akteure der ...
(Date:3/26/2015)... 26 de março de 2015 A Finesse ... é projetado especificamente para os inovadores, visionários e executivos ... dias, apenas por convite, será realizada no Hyatt Regency ... 21 e 22 de setembro de 2015. Será um ... o futuro da fabricação de produtos biofarmacêuticos de uso ...
Breaking Medicine Technology:Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2
... Biopharmaceutical Services, Inc. announced today that the U.S. ... for an Electronic Submissions Gateway (ESG) to the ... clients a validated, direct electronic path for IND ... BLA (Biologic License Application) submissions and builds upon ...
... Gamma Knife® Perfexion™ earned the number one ranking in the ... in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion ... In the report, Perfexion scored 92.9 out of ... again. On a 1 to 9 scale, Perfexion received an ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: